Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

595 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-β-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumab.
Panza F, Frisardi V, Imbimbo BP, Seripa D, Paris F, Santamato A, D'Onofrio G, Logroscino G, Pilotto A, Solfrizzi V. Panza F, et al. Among authors: pilotto a. Curr Alzheimer Res. 2011 Dec;8(8):808-17. doi: 10.2174/156720511798192718. Curr Alzheimer Res. 2011. PMID: 21592055 Review.
Solanezumab for the treatment of mild-to-moderate Alzheimer's disease.
Imbimbo BP, Ottonello S, Frisardi V, Solfrizzi V, Greco A, Seripa D, Pilotto A, Panza F. Imbimbo BP, et al. Among authors: pilotto a. Expert Rev Clin Immunol. 2012 Feb;8(2):135-49. doi: 10.1586/eci.11.93. Expert Rev Clin Immunol. 2012. PMID: 22288451 Review.
Progresses in treating agitation: a major clinical challenge in Alzheimer's disease.
Panza F, Solfrizzi V, Seripa D, Imbimbo BP, Santamato A, Lozupone M, Prete C, Greco A, Pilotto A, Logroscino G. Panza F, et al. Among authors: pilotto a. Expert Opin Pharmacother. 2015;16(17):2581-8. doi: 10.1517/14656566.2015.1092520. Epub 2015 Sep 21. Expert Opin Pharmacother. 2015. PMID: 26389682 Review.
595 results